Cargando…
Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
BACKGROUND: Neurotensin is involved in fatty acid and glucose metabolism and promotes the development of obesity and diabetes. These associations appear to be more pronounced in women. We investigated the association of neurotensin with long-term major adverse cardiovascular events (MACE) in patient...
Autores principales: | Tscharre, Maximilian, Farhan, Serdar, Freynhofer, Matthias K., Leutner, Michael, Baumgartner-Parzer, Sabina, Tentzeris, Ioannis, Vogel, Birgit, Tinhofer, Florian, Rohla, Miklos, Weiss, Thomas W., Huber, Kurt, Kautzky-Willer, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957262/ https://www.ncbi.nlm.nih.gov/pubmed/35345492 http://dx.doi.org/10.3389/fcvm.2022.782602 |
Ejemplares similares
-
Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
por: Farhan, Serdar, et al.
Publicado: (2016) -
A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
por: Leutner, Michael, et al.
Publicado: (2019) -
Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016) -
Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA): A cluster-randomized trial
por: Rohla, Miklos, et al.
Publicado: (2018) -
Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
por: Rohla, Miklos, et al.
Publicado: (2016)